Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Epilepsy Behav. 2020 Nov 24;113:107550. doi: 10.1016/j.yebeh.2020.107550

Figure 1.

Figure 1

A. Yearly prevalence of adults with epilepsy co-dispensed oral anticoagulants (OACs) with ≥1 enzyme inducing antiepileptic drugs (EI-AEDs) versus only non-enzyme inducing anti epileptic drugs (NEI-AEDs), 2010-2018

B. Yearly prevalence of adults with epilepsy co-dispensed specific direct-acting oral anticoagulants (DOACs) with ≥1 enzyme inducing antiepileptic drugs (EI-AEDs) versus only non-enzyme inducing anti epileptic drugs (NEI-AEDs), 2010-2018

Abbreviations: DOAC=direct-acting oral anticoagulant; EI-AED=enzyme-inducing antiepileptic drug; NEI-AED=non-enzyme-inducing antiepileptic drug; OAC=oral anticoagulant